Arch Pharmalabs Limited
52W HIGH
Rs 110.33
52W LOW
Rs 76.67
1Y RETURN
+22.0%
About the Company
Arch Pharmalabs is an API and pharmaceutical intermediates manufacturer with WHO-GMP certified facilities serving domestic and international formulation companies.
Quick Facts
As of 7 Jul 2026
Quantity
Minimum investment Rs 1,00,000 (1,070 shares).
Settled in T+1 days. KYC verified dealers.
Get Arch Pharmalabs Limited's live price
Share a few details and our desk sends you the latest price, availability and how to invest.
Trusted by 5,000+ investors · your details are never shared.
FUNDAMENTALS
Key Indicators
A snapshot of Arch Pharmalabs Limited's valuation multiples and capital efficiency at a glance.
CURRENT SHARE PRICE
Rs 93.5
FACE VALUE / SHARE
Rs 10
BOOK VALUE / SHARE
Rs 54.16
PRICE TO EARNING (PE)
10.90
PRICE / BOOK
1.57
MARKET CAP
1.46K Cr
DEBT TO EQUITY
1.01
RETURN ON EQUITY
12%
52 WEEK HIGH
Rs 110.33
52 WEEK LOW
Rs 76.67
FINANCIALS
Fundamentals & Financial Statements
Price / Share
₹85
P/E Ratio
10.90
P/B Ratio
1.57
Debt to Equity
1.01
Book Value
₹54.16
Face Value
₹10
| Particulars | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 706 | 1,309 | 1,341 |
| Cost of Material Consumed | 444 | 1,052 | 1,062 |
| Change in Inventory | 21 | -68 | -37 |
| Gross Margins | 37.11% | 19.63% | 20.81% |
| Employee Benefit Expenses | 74 | 75 | 69 |
| Other Expenses | 892 | 73 | 67 |
| EBITDA | -725 | 177 | 180 |
| OPM | -102.69% | 13.52% | 13.42% |
| Other Income | 2,853 | -1 | 1 |
| Finance Cost | 231 | 98 | 35 |
| Depreciation & Amortisation | 28 | 25 | 23 |
| EBIT | -753 | 152 | 157 |
| EBIT Margins | -106.66% | 11.61% | 11.71% |
| Profit Before Tax | 1,869 | 52 | 122 |
| PBT Margins | 264.73% | 3.97% | 9.1% |
| Tax | 0 | 0 | 0 |
| Profit After Tax | 1,869 | 52 | 122 |
| Net Profit Margin | 264.73% | 3.97% | 9.1% |
| EPS | ₹123.03 | ₹3.42 | ₹7.8 |
PROCESS
How to Buy Arch Pharmalabs Limited
Enquire
Share your requirement and preferred quantity with our desk.
Get a quote
Receive the latest indicative price, lot size and availability.
Complete KYC
Quick paperwork with a KYC-verified counterparty.
Receive shares
Shares credited to your demat, typically within T+1 days.
OWNERSHIP
Shareholding Pattern
Indicative ownership structure. Exact filed breakup confirmed at dealing.
CORPORATE CALENDAR
Events & Announcements
Typical annual calendar. Exact dates updated as the company announces them.
LEADERSHIP
Management Team
Standard governance structure. Named directors added as verified. Tap any role to see what they do and why it matters for investors.
REPORTS
Download Financial Results
Arch Pharmalabs Limited Financial Report
Fundamentals, financial statements and key ratios in one PDF
Need the official filed reports?
Get audited annual & quarterly filings (MCA / RTA) for Arch Pharmalabs Limited straight from our desk.
QUESTIONS
Frequently Asked Questions
NEWS & INSIGHTS
Latest on Arch Pharmalabs Limited & its sector
CORPORATE
Company Details
ISIN
INE182F01017
CIN
U24231MH1993PLC150891
PAN
AACCM0306Q
REGISTRAR (RTA)
Link Intime
DEPOSITORY
NSDL & CDSL
SECTOR
Healthcare
INDUSTRY
API Manufacturing
READY TO INVEST?
Enquire with Neoma Capital
Talk to a CA advisor about Arch Pharmalabs Limited. Get pricing, availability, and transfer process guidance.
Disclaimer: Prices shown are indicative and for reference purposes only. Unlisted shares carry higher risk than listed equities. Past performance is not indicative of future results. Financial statements, where shown, are compiled from company filings (MCA / RTA) and may be restated in subsequent filings. Neoma Capital does not provide investment advice. Please consult a qualified financial advisor. Transactions subject to KYC verification and SEBI regulations.